Growing evidence has indicated that STAT3 signaling was involved in carcinogenesis, and immunotherapy response through regulating cancer cell differentiation and proliferation in human squamous cell carcinoma (Zhou et al., 2015; Zhao et al., 2018). This evidence concerns the gene STAT3 and squamous cell carcinoma.